1. Signaling Pathways
  2. MAPK/ERK Pathway
    Stem Cell/Wnt
  3. ERK
  4. ERK Isoform

ERK

 

ERK Related Products (81):

Cat. No. Product Name Effect Purity
  • HY-100489
    TBHQ
    Activator 99.76%
    TBHQ (tert-Butylhydroquinone) is a widely used Nrf2 activator, protects against Doxorubicin (DOX)-induced cardiotoxicity through activation of Nrf2.
  • HY-19696
    Tauroursodeoxycholate
    Inhibitor ≥98.0%
    Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor.
  • HY-19696A
    Tauroursodeoxycholate sodium
    Inhibitor 98.63%
    Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor.
  • HY-B0185
    Lidocaine
    Inhibitor 99.96%
    Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence.
  • HY-108635
    C16-PAF
    Activator 99.48%
    C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR).
  • HY-12764
    6-OAU
    Inhibitor 99.91%
    6-OAU (GTPL5846) (6-n-octylaminouracil) is an GPR84 (G protein-coupled receptor 84) agonist, with an EC50 value of 105 nM.
  • HY-19700
    trans-Zeatin
    Inhibitor 99.83%
    trans-Zeatin is a plant cytokinin, which plays an important role in cell growth, differentiation, and division; trans-Zeatin also inhibits UV-induced MEK/ERK activation.
  • HY-B0185A
    Lidocaine hydrochloride
    Inhibitor 99.81%
    Lidocaine hydrochloride (Lignocaine hydrochloride) inhibits sodium channels involving complex voltage and using dependence.
  • HY-104047
    LM22B-10
    Activator 99.72%
    LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor, and can induce TrkB, TrkC, AKT and ERK activation in vitro and in vivo.
  • HY-W010907
    Pamoic acid disodium
    Activator ≥98.0%
    Pamoic acid disodium is a potent GPR35 agonist with an EC50 value of 79 nM.
  • HY-N0371
    Pachymic acid
    Inhibitor ≥99.0%
    Pachymic acid is a lanostrane-type triterpenoid from P.
  • HY-15816A
    Ulixertinib hydrochloride
    Inhibitor 99.89%
    Ulixertinib hydrochloride (BVD-523 hydrochloride) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2.
  • HY-W008613
    Pamoic acid
    Agonist 98.63%
    Pamoic acid is a potent GPR35 agonist with an EC50 of 79 nM.
  • HY-120006A
    (rel)-AR234960
    Agonist 99.47%
    (rel)-AR234960 is an active relative configuration of AR234960.
  • HY-137977
    DMU-212
    Activator 99.91%
    DMU-212 is a methylated derivative of Resveratrol (HY-16561), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities.
  • HY-P1844A
    Chemerin-9 (149-157) (TFA)
    Inducer 99.64%
    Chemerin-9 (149-157) TFA is a potent agonist of chemokine-like receptor 1 (CMKLR1) .
  • HY-N8418
    Cearoin
    Activator ≥98.0%
    Cearoin increases autophagy and apoptosis through the production of ROS and the activation of ERK.
  • HY-101364A
    CHPG sodium salt
    Activator 99.17%
    CHPG sodium salt is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells.
  • HY-N6257
    Cafestol
    Inhibitor 99.91%
    Cafestol, one of the major components of coffee, is a coffee-specific diterpene from.
  • HY-101364
    CHPG
    Activator ≥99.0%
    CHPG is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells.